194 related articles for article (PubMed ID: 15573254)
1. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
[TBL] [Abstract][Full Text] [Related]
2. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
Teh M; Wee A; Raju GC
Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
[TBL] [Abstract][Full Text] [Related]
4. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.
Hoang MP; Murakata LA; Katabi N; Henson DE; Albores-Saavedra J
Mod Pathol; 2002 Dec; 15(12):1251-8. PubMed ID: 12481004
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterisation of six human biliary tract cancer cell lines.
Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular biology of biliary tract cancers.
Rashid A
Surg Oncol Clin N Am; 2002 Oct; 11(4):995-1009. PubMed ID: 12607585
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
Washington K; Gottfried MR
Liver; 1996 Apr; 16(2):99-104. PubMed ID: 8740842
[TBL] [Abstract][Full Text] [Related]
9. Frequency of loss expression of the DPC4 protein in various locations of biliary tract carcinoma.
Tang Z; Zou S; Hao Y; Wang B; Yang X; Qiu F
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):481-4. PubMed ID: 12411149
[TBL] [Abstract][Full Text] [Related]
10. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Jang JJ
Hum Pathol; 2002 Sep; 33(9):877-83. PubMed ID: 12378511
[TBL] [Abstract][Full Text] [Related]
11. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival.
Diamantis I; Karamitopoulou E; Perentes E; Zimmermann A
Hepatology; 1995 Sep; 22(3):774-9. PubMed ID: 7657282
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct.
Tascilar M; Offerhaus GJ; Altink R; Argani P; Sohn TA; Yeo CJ; Cameron JL; Goggins M; Hruban RH; Wilentz RE
Am J Clin Pathol; 2001 Dec; 116(6):831-7. PubMed ID: 11764071
[TBL] [Abstract][Full Text] [Related]
13. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
Lee CS; Pirdas A
Pathology; 1995 Apr; 27(2):117-20. PubMed ID: 7567135
[TBL] [Abstract][Full Text] [Related]
14. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
15. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.
Lee CS
Eur J Surg Oncol; 1997 Jun; 23(3):233-7. PubMed ID: 9236898
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Hahn SA; Bartsch D; Schroers A; Galehdari H; Becker M; Ramaswamy A; Schwarte-Waldhoff I; Maschek H; Schmiegel W
Cancer Res; 1998 Mar; 58(6):1124-6. PubMed ID: 9515793
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder.
Duval JV; Savas L; Banner BF
Arch Pathol Lab Med; 2000 Aug; 124(8):1196-200. PubMed ID: 10923083
[TBL] [Abstract][Full Text] [Related]
18. Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases.
Maitra A; Krueger JE; Tascilar M; Offerhaus GJ; Angeles-Angeles A; Klimstra DS; Hruban RH; Albores-Saavedra J
Am J Surg Pathol; 2000 Nov; 24(11):1501-10. PubMed ID: 11075851
[TBL] [Abstract][Full Text] [Related]
19. Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts.
Kuo KK; Sato N; Mizumoto K; Maehara N; Yonemasu H; Ker CG; Sheen PC; Tanaka M
Hepatology; 2000 Jan; 31(1):59-64. PubMed ID: 10613729
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.
Ajiki T; Onoyama H; Yamamoto M; Asaka K; Fujimori T; Maeda S; Saitoh Y
Hepatogastroenterology; 1996; 43(9):521-6. PubMed ID: 8799388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
